Patent foramen ovale: Friend or foe?

Journal of the American College of Cardiology

Volumn 42, Issue 6, 2003, Pages 1073-1075

  Castello, Ramon ^a   Brott, Thomas G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

CAROTID ENDARTERECTOMY; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; DISEASE PREDISPOSITION; HEART ANEURYSM; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; NOTE; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STENT; STROKE; THROMBOEMBOLISM;

EID: 0042735258     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00906-9     Document Type: Editorial

References (37)

1. Rodriguez C, Homma S, Di Tullio M. Transesophageal echocardiography in stroke. Cardiol Rev 2000;8:140-7.
2. Castello R, Pearson AC, Labovitz AJ. Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography. Am J Cardiol 1990;65:1149-53.
3. Daniel WG, Angermann C, Engberding R, et al. Transesophageal echocardiography in patients with cerebral ischemic events and arterial embolism: a European multicenter study. Circulation 1989;80:II-473.
4. Pearson AC, Nagelhout D, Castello R, et al. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol 1991;18:1223-9.
5. Mugge A, Henning K, Daniel WG. The role of transesophageal echocardiography in the detection of left atrial thrombi. Echocardiography 1993;10:405-17.
6. Leung DY, Black IW, Cranney GB, et al. Prognostic implications of left atrial spontaneous echocontrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 1994;24:755-62.
7. Amarenco P, Duyckaerts C, Tzourio C, et al. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992;332:221-5.
8. Dressler FA, Craig WR, Castello R, et al. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology, on recurrent stroke. J Am Coll Cardiol 1998;31:134-8.
9. Fagan S, Chan KL. Transesophageal echocardiography risk factors for stroke in nonvalvular atrial fibrillation. Echocardiography 2000;17:365-72.
10. Zabalgoitia M, Halperin JL, Pearce LA, et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation: stroke prevention in atrial fibrillation III investigators. J Am Coll Cardiol 1998;31:1622-6.
11. Labovitz AJ, for the STEPS Investigators. Transesophageal echocardiography and unexplained cerebral ischemia: a multicenter follow-up study. Am Heart J 1999;137:1082-7.
12. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patients foramen ovale or atrial septal aneurysm or both, and cryptogenic stroke or TIA: French study group on PFO and ASA. Am Heart J 1995;140:1083-8.
13. Di Tullio MR, Sacco RI, Gersony D, et al. Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology 1996;46:1560-6.
14. The SPARC Study. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography, carotid ultrasonography. Mayo Clin Proc 1999;74:862-9.
15. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-9.
16. Homma S, Sacco R, Di Tullio M, Sciacca R, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation 2002;105:2625-31.
17. Lechat P, Mas JL, Lescault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-52.
18. Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
19. Hagen PT, Scholz DG, Edwards WD. Incidence and size of PFO during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
20. Halperin JL, Fuster V. Patent foramen ovale and recurrent stroke: another paradoxical twist. Circulation 2002;105:2580-2.
21. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, and the PICSS Investigators. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy. J Am Coll Cardiol 2003;42:1066-72.
22. Berthet K, Laverne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000;31:398-403.
23. Mugge A, Daniel WG, Angermann C, et al. Atrial septal aneurysm in adult patients: a multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995;91:2785-92.
24. Agmon Y, Khandheria B, Meissner I, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999;99:1942-4.
25. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-6.
26. Mohr JP, Lazar RM, Thompson JLP, et al., Warfarin-Aspirin Recurrent Stroke Study (WARSS) Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-51.
27. Chiari H. Uber Netzbildungen im rechten Vorhof des Herzens. Beitr Pathol Anat 1897;22:1-10.
28. Schneider B, Hofmann T, Justen MH, Meinertz T. Chiari's network: normal anatomic variant or risk factor for arterial embolic events. J Am Coll Cardiol 1995;26:203-10.
29. Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Stroke 2002;33:706-11.
30. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003;107:5-9.
31. Wahl A, Windecker S, Eberli F, Seiler C, Meier B. Percutaneous closure of patent foramen ovale in symptomatic patients. J Interven Cardiol 2001;14:203-10.
32. Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997;28:2376-81.
33. Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100:II171-5.
34. Goldstein JA, Beardslee MA, Xu H, Sundt TM, Lasala JM. Infective endocarditis resulting from cardioSEAL closure of a patent foramen ovale. Cathet Cardiovasc Intervent 2002;55:217-20.
35. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-53.
36. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1996;273:1421-7.
37. Blackshear JL, Brott TG. Transesophageal echocardiography in source-of-embolism evaluation: the search for a better therapeutic rationale. Mayo Clin Proc 1999;74:941-5.